228 related articles for article (PubMed ID: 28078116)
1. Pretreatment tumor volume as a prognostic factor in metastatic colorectal cancer treated with selective internal radiation to the liver using yttrium-90 resin microspheres.
Bhooshan N; Sharma NK; Badiyan S; Kaiser A; Moeslein FM; Kwok Y; Amin PP; Kudryasheva S; Chuong MD
J Gastrointest Oncol; 2016 Dec; 7(6):931-937. PubMed ID: 28078116
[TBL] [Abstract][Full Text] [Related]
2. Correlation of radiation dose and activity with clinical outcomes in metastatic colorectal cancer after selective internal radiation therapy using yttrium-90 resin microspheres.
Badiyan S; Bhooshan N; Chuong MD; Sharma N; Akhter N; Etezadi V; Hausner P; Kudryasheva S; Kaiser A; Becker S; Guerrero M; Yi BY
Nucl Med Commun; 2018 Oct; 39(10):915-920. PubMed ID: 30124600
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy.
Sofocleous CT; Garcia AR; Pandit-Taskar N; Do KG; Brody LA; Petre EN; Capanu M; Longing AP; Chou JF; Carrasquillo JA; Kemeny NE
Clin Colorectal Cancer; 2014 Mar; 13(1):27-36. PubMed ID: 24370352
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and Predictors of Toxicity after Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres for Unresectable Hepatocellular Carcinoma.
Gabrielson A; Miller A; Banovac F; Kim A; He AR; Unger K
Front Oncol; 2015; 5():292. PubMed ID: 26779437
[TBL] [Abstract][Full Text] [Related]
5. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
Gibbs P; Gebski V; Van Buskirk M; Thurston K; Cade DN; Van Hazel GA;
BMC Cancer; 2014 Dec; 14():897. PubMed ID: 25487708
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT).
Beuzit L; Edeline J; Brun V; Ronot M; Guillygomarc'h A; Boudjema K; Gandon Y; Garin E; Rolland Y
Eur J Radiol; 2016 Aug; 85(8):1445-52. PubMed ID: 27423686
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy.
D'Emic N; Engelman A; Molitoris J; Hanlon A; Sharma NK; Moeslein FM; Chuong MD
J Gastrointest Oncol; 2016 Apr; 7(2):269-77. PubMed ID: 27034796
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy.
Gulec SA; Suthar RR; Barot TC; Pennington K
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1289-95. PubMed ID: 21461737
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
[TBL] [Abstract][Full Text] [Related]
10. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases.
Stubbs RS; Cannan RJ; Mitchell AW
J Gastrointest Surg; 2001; 5(3):294-302. PubMed ID: 11360053
[TBL] [Abstract][Full Text] [Related]
11. The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.
Pardo F; Sangro B; Lee RC; Manas D; Jeyarajah R; Donckier V; Maleux G; Pinna AD; Bester L; Morris DL; Iannitti D; Chow PK; Stubbs R; Gow PJ; Masi G; Fisher KT; Lau WY; Kouladouros K; Katsanos G; Ercolani G; Rotellar F; Bilbao JI; Schoen M
Ann Surg Oncol; 2017 Sep; 24(9):2465-2473. PubMed ID: 28653161
[TBL] [Abstract][Full Text] [Related]
12. Regorafenib Prior to Selective Internal Radiation Therapy Using
Kennedy A; Shipley D; Shpak M; Blakely L; Hemphill B; Shih K; Lane C; Zimmerman L; McKenzie A; Mainwaring M; Peyton JD; Zubkus J; Wright D; Singh J; Bendell JC
Front Oncol; 2019; 9():624. PubMed ID: 31355141
[No Abstract] [Full Text] [Related]
13. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.
Fendler WP; Philippe Tiega DB; Ilhan H; Paprottka PM; Heinemann V; Jakobs TF; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2013 Aug; 54(8):1202-8. PubMed ID: 23729697
[TBL] [Abstract][Full Text] [Related]
14. Administered activity and outcomes of glass versus resin (90)Y microsphere radioembolization in patients with colorectal liver metastases.
Srinivas SM; Nasr EC; Kunam VK; Bullen JA; Purysko AS
J Gastrointest Oncol; 2016 Aug; 7(4):530-9. PubMed ID: 27563442
[TBL] [Abstract][Full Text] [Related]
15. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
Werner-Wasik M; Xiao Y; Pequignot E; Curran WJ; Hauck W
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):56-61. PubMed ID: 11516851
[TBL] [Abstract][Full Text] [Related]
16. Role of Resin Microsphere Y90 Dosimetry in Predicting Objective Tumor Response, Survival and Treatment Related Toxicity in Surgically Unresectable Colorectal Liver Metastasis: A Retrospective Single Institution Study.
Sankhla T; Cheng B; Nezami N; Xing M; Sethi I; Bercu Z; Brandon D; Majdalany B; Schuster DM; Kokabi N
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638392
[TBL] [Abstract][Full Text] [Related]
17. Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes.
Mafeld S; Littler P; Hayhurst H; Manas D; Jackson R; Moir J; French J
J Gastrointest Cancer; 2020 Mar; 51(1):152-158. PubMed ID: 30911980
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
19. Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres.
Jakobs TF; Hoffmann RT; Poepperl G; Schmitz A; Lutz J; Koch W; Tatsch K; Lubiensky A; Reiser MF; Helmberger T
Eur Radiol; 2007 May; 17(5):1320-30. PubMed ID: 17149621
[TBL] [Abstract][Full Text] [Related]
20. Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.
Xing M; Prajapati HJ; Dhanasekaran R; Lawson DH; Kokabi N; Eaton BR; Kim HS
Am J Clin Oncol; 2017 Feb; 40(1):27-34. PubMed ID: 25089529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
